CBAY - CymaBay Therapeutics Inc. (CBAY) CEO Sujal Shah on Q1 2020 Results - Earnings Call Transcript
CymaBay Therapeutics, Inc. (CBAY)
Q1 2020 Earnings Conference Call
May 11, 2020 04:30 PM ET
Company Participants
Dan Menold - Vice President, Finance
Sujal Shah - President and Chief Executive Officer
Charles McWherter - Senior Vice President and Chief Scientific Officer
Klara Dickinson - Chief Regulatory and Compliance Officer
Chuck McWherter - Chief Scientific Officer
Dr. Paul Watkins - Chair of Expert Review Panel
Dr. David Kleiner - Head of the Drug-Induced Liver Injury Network at NIH
Dr. Stephen Harrison - Principal Investigator NASH Program
Conference Call Participants
Yasmeen Rahimi - ROTH Capital Partners
Eliana